Profit before tax (PBT) stood at Rs 40.26 crore in Q3 December 2019, up 56.8% from Rs 25.67 crore in Q3 December 2018.

Net sales rose 7.3% to Rs 785.19 crore in Q3 December 2019 from Rs 732.10 crore in Q3 December 2018. The result was announced after market hours yesterday.

Consolidated EBITDA stood at Rs 108.2 crore as against Rs 81.2 crore in Q3 FY19, translating into a YoY growth of 33.2%.

As on 31 December 2019, the consolidated net debt was Rs 569.8 crore representing a net debt to equity ratio of 0.50 (out of which, debt worth $49.5 million is denominated in foreign currency).

Commenting on the performance, Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, said "With this period being a seasonally moderate one, we are pleased to sustain the momentum generated over the last four quarters delivering robust operational profits. This has been achieved on the back of decent growth registered by our hospitals across the network despite shutting down of operations at our Whitefield facility which reported revenues of Rs 37.8 crore in H1 FY20 with an EBITDA margin of 18.6%. With patient well-being at its core, NH is committed to driving excellence across the clinical spectrum and continues to invest resources to reinforce its reputation to deliver quality affordable healthcare across all sections of society."

Narayana Hrudayalaya is a healthcare service provider, operating a chain of multispecialty, tertiary and primary healthcare facilities. The company has a network of 21 hospitals and 6 heart centres across India and single hospital overseas at Cayman Islands.

Following the result, shares of Narayana Hrudayalaya slipped 1.38% to Rs 372.65.